Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor.

Front Pharmacol · 2019 · PMC6611384 · PMID 31316377

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The results showed no statistically significant difference between treated and placebo groups; the week 10 analysis showed a trend for increased efficacy (15 vs. 12% at week 6 and 27 vs. 12% at week 10 in treated and placebo group, respectively) ( Sands et al., 2014 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.